{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T21:45:43Z","timestamp":1776203143930,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clineuro.2024.108493","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T01:43:59Z","timestamp":1723081439000},"page":"108493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Early-morning OFF in Parkinson\u2019s disease: A systematic literature review and current therapeutics"],"prefix":"10.1016","volume":"245","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4157-5447","authenticated-orcid":false,"given":"Hiroshi","family":"Kataoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Sugie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2024.108493_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00702-010-0424-5","article-title":"The wearing-off phenomenon and the use of questionnaires to facilitate its recognition in Parkinson\u2019s disease","volume":"117","author":"Stacy","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.clineuro.2024.108493_bib2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1185\/03007990902779319","article-title":"Levodopa-related wearing-off in Parkinson\u2019s disease: identification and management","volume":"25","author":"Pahwa","year":"2009","journal-title":"Curr. Med Res Opin."},{"key":"10.1016\/j.clineuro.2024.108493_bib3","article-title":"Nocturnal Sleep Problems Mediate the Impact on Quality of Life of Early Morning Off in Parkinson\u2019s Disease","volume":"13","author":"Zhang","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.clineuro.2024.108493_bib4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mds.20279","article-title":"Impact of the motor complications of Parkinson's disease on the quality of life","volume":"20","author":"Chapuis","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2024.108493_bib5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.parkreldis.2014.09.013","article-title":"EUROPAR and the IPDMDS non-Motor PD Study Group. Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: An international multicenter study.","volume":"20","author":"Rizos","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.clineuro.2024.108493_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2016.02.066","article-title":"The impact of early morning off in Parkinson's disease on patient quality of life and caregiver burden","volume":"15","author":"Onozawa","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2024.108493_bib7","article-title":"Evaluation of morning bradykinesia in Parkinson\u2019s disease in a United States cohort using continuous objective monitoring","volume":"6","author":"Isaacson","year":"2022","journal-title":"Clin. Park Relat. Disord."},{"key":"10.1016\/j.clineuro.2024.108493_bib8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/mdc3.13520","article-title":"Characterization of Non-Motor Fluctuations Using the Movement Disorder Society Non-Motor Rating Scale.","volume":"9","author":"van Wamelen","year":"2022","journal-title":"Mov. Disord. Clin. Pr."},{"key":"10.1016\/j.clineuro.2024.108493_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clineuro.2024.108493_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2018.02.001","article-title":"The spectrum of \u201coff\u201d in Parkinson's disease: what have we learned over 40 years?","volume":"51","author":"Chou","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.clineuro.2024.108493_bib11","article-title":"Evaluation of Motor Complications in Parkinson\u2019s Disease: Understanding the Perception Gap between Patients and Physicians","volume":"2021","author":"Ogura","year":"2021","journal-title":"Park. Dis."},{"key":"10.1016\/j.clineuro.2024.108493_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz203","article-title":"Quantitative associations between objective sleep measures and early-morning mobility in Parkinson's disease: cross-sectional analysis of the PHASE study","volume":"43","author":"Kataoka","year":"2020","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.clineuro.2024.108493_bib13","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1007\/s11033-023-08409-1","article-title":"Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson's disease: an overview and update on new developments","volume":"50","author":"Zamanian","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.clineuro.2024.108493_bib14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/ene.13895","article-title":"and levodopa dose failures in patients with Parkinson\u2019s disease attending a routine clinical appointment using Time-to-ON Questionnaire","volume":"26","author":"Stocchi","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2024.108493_bib15","article-title":"Does the Response to Morning Medication Predict the ADL-Level of the Day in Parkinson's Disease?\"Parkinsons","author":"H\u00f8rmann Thomsen","year":"2020","journal-title":"Dis"},{"key":"10.1016\/j.clineuro.2024.108493_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF03351014","article-title":"Circadian variation in plasma dopamine levels in man","volume":"7","author":"Sowers","year":"1984","journal-title":"J. Endocrinol. Invest"},{"key":"10.1016\/j.clineuro.2024.108493_bib17","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2024.108493_bib18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1212\/01.wnl.0000215250.82576.87","article-title":"Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology","volume":"66","author":"Pahwa","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2024.108493_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/mds.26125","article-title":"Clinical spectrum of levodopa induced complications","volume":"30","author":"Aquino","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2024.108493_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00002826-198604000-00009","article-title":"Delayed onset of responses to single doses of L-dopa in parkinsonian fluctuators on long-term L-dopa therapy","volume":"9","author":"Melamed","year":"1986","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.clineuro.2024.108493_bib21","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1517\/14656566.7.10.1399","article-title":"The levodopa wearing-off phenomenon in Parkinson\u2019s disease: pharmacokinetic considerations","volume":"7","author":"Stocchi","year":"2006","journal-title":"Expert Opin. Pharm."},{"key":"10.1016\/j.clineuro.2024.108493_bib22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s disease","volume":"14","author":"Fasano","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2024.108493_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.parkreldis.2011.12.004","article-title":"Gastroparesis and Parkinson\u2019s disease: a systematic review","volume":"18","author":"Heetun","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.clineuro.2024.108493_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/mds.25708","article-title":"Delayed gastric emptying in Parkinson's disease","volume":"29","author":"Marrinan","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2024.108493_bib25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mds.20279","article-title":"Impact of the motor complications of Parkinson's disease on the quality of life","volume":"20","author":"Chapuis","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2024.108493_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.parkreldis.2014.02.019","article-title":"Small intestinal bacterial overgrowth in Parkinson's disease","volume":"20","author":"Tan","year":"2014","journal-title":"Park. Relat. Disord."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108493_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson's disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2024.108493_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.17925\/ENR.2013.08.02.82","article-title":"KRC. Morning akinesia and the potential role of gastroparesis\u2014managing delayed onset of first daily dose of oral levodopa in patients with Parkinson\u2019s disease","volume":"8","author":"Isaacson","year":"2013","journal-title":"Eur. Neurol. Rev."},{"key":"10.1016\/j.clineuro.2024.108493_bib29","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s40120-023-00533-1","article-title":"Continuous Subcutaneous Foslevodopa\/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study","volume":"12","author":"Aldred","year":"2023","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.clineuro.2024.108493_bib30","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/mds.28926","article-title":"A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ-009","volume":"37","author":"Thijssen","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2024.108493_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.parkreldis.2019.03.026","article-title":"Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease","volume":"64","author":"Hauser","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.clineuro.2024.108493_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/mdc3.12350","article-title":"Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson\u2019s Disease","volume":"4","author":"Isaacson","year":"2017","journal-title":"Mov. Disord. Clin. Pr."},{"key":"10.1016\/j.clineuro.2024.108493_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.23441","article-title":"Recover Study Group. Rotigotine Effects on Early Morning Motor Function and Sleep in Parkinson\u2019s Disease: A Double-Blind, Randomized, Placebo-Controlled Study (RECOVER)","volume":"26","author":"Trenkwalder","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2024.108493_bib34","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00702-010-0506-4","article-title":"Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson\u2019s disease","volume":"117","author":"Giladi","year":"2010","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.clineuro.2024.108493_bib35","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10072-016-2664-0","article-title":"Motor outcomes in patients with advanced Parkinson\u2019s disease treated with levodopa\/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study","volume":"37","author":"Lopiano","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clineuro.2024.108493_bib36","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3171\/jns.2006.104.4.502","article-title":"Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease","volume":"104","author":"Lyons","year":"2006","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clineuro.2024.108493_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0090-3019(01)00533-X","article-title":"Effect of Bilateral Subthalamic Electrical Stimulation in Parkinson\u2019s Disease","volume":"56","author":"Broggi","year":"2001","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.clineuro.2024.108493_bib38","article-title":"Effectiveness and safety of safinamide in the Toledo Movement Disorders Unit","volume":"77","author":"Morales-Casado","year":"2023","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.clineuro.2024.108493_bib39","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1468-1331.2011.03512.x","article-title":"Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson\u2002s disease","volume":"18","author":"Stocchi","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2024.108493_bib40","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1517\/14656566.2015.1086748","article-title":"Rasagiline for the treatment of Parkinson\u2019s disease: an update","volume":"16","author":"Stocchi","year":"2015","journal-title":"Expert Opin. Pharm."},{"key":"10.1016\/j.clineuro.2024.108493_bib41","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s10072-023-07233-6","article-title":"Objective assessment of the effects of opicapone in Parkinson\u2019s disease through kinematic analysis","volume":"45","author":"Bologna","year":"2024","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clineuro.2024.108493_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106971","article-title":"OFF-times before, during, and after nighttime sleep periods in Parkinson's disease patients with motor fluctuations and the effects of opicapone: A post hoc analysis of diary data from BIPARK-1 and -2","volume":"123","author":"Hauser","year":"2024","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.clineuro.2024.108493_bib43","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/sj.npp.1300250","article-title":"The Effect of Cabergoline on Sleep, Periodic Leg Movements in Sleep, and Early Morning Motor Function in Patients with Parkinson\u2019s Disease","volume":"28","author":"H\u00f6gl","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clineuro.2024.108493_bib44","article-title":"Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson's Disease: a pilot study","author":"Zhou","year":"2021","journal-title":"Park. Dis."},{"key":"10.1016\/j.clineuro.2024.108493_bib45","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1212\/WNL.0b013e31822affdb","article-title":"Pramipexole ER Studies Group. Extended-release pramipexole in advanced Parkinson disease","volume":"77","author":"Schapira","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2024.108493_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2377-13-113","article-title":"Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson\u2019s disease","volume":"13","author":"Yun","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.clineuro.2024.108493_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.410120305","article-title":"Pergolide in Late-Stage Parhnson Disease","volume":"12","author":"Lang","year":"1982","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2024.108493_bib48","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/WNL.46.4.1059","article-title":"Early morning akinesia in Parkinson\u2019s disease: Effect of standard carbidopa\/levodopa and sustained-release carbidopa\/levodopa","volume":"46","author":"Pahwa","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2024.108493_bib49","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archneur.1987.00520220016008","article-title":"Controlled Release Levodopa-Carbidopa (CR-5) in the Management of Parkinsonian Motor Fluctuations","volume":"44","author":"Juncos","year":"1987","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clineuro.2024.108493_bib50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1212\/WNL.43.4.677","article-title":"Clinical experience with controlled-release carbidopa\/levodopa in Parkinson's disease","volume":"43","author":"Pahwa","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2024.108493_bib51","article-title":"Nocturnal Sleep Problems Mediate the Impact on Quality of Life of Early Morning Off in Parkinson\u2019s Disease","volume":"13","author":"Zhang","year":"2021","journal-title":"Front Aging Neurosci."},{"issue":"34","key":"10.1016\/j.clineuro.2024.108493_bib52","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1523\/JNEUROSCI.1443-08.2008","article-title":"Sleep deprivation decreases binding of [11C]raclopride to dopamine D2\/D3 receptors in the human brain","volume":"28","author":"Volkow","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clineuro.2024.108493_bib53","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1523\/JNEUROSCI.0045-12.2012","article-title":"Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain","volume":"32","author":"Volkow","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clineuro.2024.108493_bib54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4274\/tjps.galenos.2021.95226","article-title":"Non-Oral Drug Delivery in Parkinson\u2019s Disease: Current Applications and Future","volume":"19","author":"G\u00fcne\u015f","year":"2022","journal-title":"Turk. J. Pharm. Sci."},{"key":"10.1016\/j.clineuro.2024.108493_bib55","article-title":"Non-oral dopaminergic therapies for Parkinson\u2019s disease: current treatments and the future","volume":"2","author":"Ray Chaudhuri","year":"2016","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.clineuro.2024.108493_bib56","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2174\/1570159X15666170510143821","article-title":"Levodopa in Parkinson\u2019s Disease: Current Status and Future Developments","volume":"16","author":"Tambasco","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.clineuro.2024.108493_bib57","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/WCO.0000000000001166","article-title":"Parkinson's disease - current treatment","volume":"36","author":"Wang","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.clineuro.2024.108493_bib58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2169\/internalmedicine.8940-21","article-title":"Recent Advances in Drug Therapy for Parkinson\u2019s Disease","volume":"62","author":"Murakami","year":"2023","journal-title":"Intern Med"},{"key":"10.1016\/j.clineuro.2024.108493_bib59","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1468-1331.2011.03614.x","article-title":"Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial","volume":"19","author":"Nyholm","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2024.108493_bib60","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/mds.22922","article-title":"Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study","volume":"25","author":"Rascol","year":"2010","journal-title":"Mov. Disord."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724003809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724003809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T07:42:59Z","timestamp":1725694979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846724003809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":60,"alternative-id":["S0303846724003809"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108493","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early-morning OFF in Parkinson\u2019s disease: A systematic literature review and current therapeutics","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108493"}}